Clinical Trial Update: Utility of ICG in Benign Bone Tumors [EARLY_Phase 1]

View source ↗

Summary

An early-phase (Phase 1) trial evaluating the utility of indocyanine green (ICG) imaging for benign bone tumors; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Bone Tumor

Drugs mentioned

• Indocyanine Green (Indocyanine Green)

Snippet

Sponsor: Dartmouth-Hitchcock Medical Center | Conditions: Bone Tumor | EARLY_Phase 1 | Status: COMPLETED